SYRE Enterprise Value
$1.14 B
+$4.11 M+0.36%
Fri, 17 Jan 2025 21:02:38 GMT
Summary:
As of January 21, 2025, SYRE enterprise value is $1.14 billion, with a rise of +$4.11 million (+0.36%) during the most recent trading day. Over the past year, it has increased by +$550.44 million (+93.53%). SYRE enterprise value is now -44.23% below its all-time high of $2.04 billion.SYRE Enterprise Value Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SYRE Enterprise Value Performance
| PeriodPeriod | Enterprise valueEnterprise value | Market capMarket cap | PricePrice |
|---|---|---|---|
| todaytoday | +0.4% | +0.3% | +0.3% |
| 1 m1 month | -21.7% | -20.7% | -20.7% |
| 3 m3 months | -29.4% | -28.1% | -37.1% |
| 6 m6 months | -27.4% | -25.0% | -35.2% |
| ytdytd | -9.3% | -8.8% | -8.8% |
| 1 y1 year | +93.5% | +55.7% | -4.4% |
| 5 y5 years | +425.5% | +424.2% | -89.6% |
SYRE Enterprise Value High & Low
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | $1.45 B | -21.7% | $1.13 B | +0.7% |
| 3 m | 3-month | $2.04 B | -44.2% | $1.13 B | +0.7% |
| 6 m | 6-month | $2.04 B | -44.2% | $474 M | +140.1% |
| 1 y | 1-year | $2.04 B | -44.2% | $474 M | +140.1% |
| 3 y | 3-year | $2.04 B | -44.2% | -$224 M | +608.2% |
| 5 y | 5-year | $2.04 B | -44.2% | -$224 M | +608.2% |
| alltime | all time | $2.04 B | -44.2% | -$224 M | +608.2% |
Spyre Therapeutics Enterprise Value History
| Date | Value |
|---|---|
| 2025 | $1.14 B(-9.3%) |
| 2024 | $1.26 B(+114.0%) |
| 2023 | $587.06 M(<-9900.0%) |
| 2022 | -$826.50 K(-100.4%) |
| 2021 | $224.35 M(-23.4%) |
| Date | Value |
|---|---|
| 2020 | $292.80 M(+40.8%) |
| 2019 | $208.02 M(+31.4%) |
| 2018 | $158.35 M(+104.7%) |
| 2017 | $77.37 M(+624.9%) |
| 2016 | $10.67 M |
FAQ
- What is Spyre Therapeutics enterprise value?
- What is the all time high enterprise value for Spyre Therapeutics?
- What is SYRE enterprise value year-to-date change?
- What is Spyre Therapeutics enterprise value year-on-year change?
What is Spyre Therapeutics enterprise value?
The current enterprise value of SYRE is $1.14 B
What is the all time high enterprise value for Spyre Therapeutics?
Spyre Therapeutics all-time high enterprise value is $2.04 B
What is SYRE enterprise value year-to-date change?
Spyre Therapeutics enterprise value has changed by -$117.41 M (-9.35%) since the beginning of the year
What is Spyre Therapeutics enterprise value year-on-year change?
Over the past year, SYRE enterprise value has changed by +$550.44 M (+93.53%)